Revenue growth target of 1.5x IPM
Management targets growing at 1.5 times the Indian Pharma Market growth, implying 12-15% revenue growth based on current IPM trends.
JAGSONPALPHARMACEUTICALS / guidance tracker
Keep management guidance in view.
Jagsonpal Pharmaceuticals · forward-looking guidance across the available source record.
Research layer active
Guidance tracker
What management said would happen.
growth
New product launches: 9-10 in FY27
Plans to launch 9-10 new products or brand extensions in FY27, with half being brand extensions and half new products in core therapies.
No increase in MR headcount
Management stated they do not intend to increase MR numbers, with growth driven entirely by productivity improvements.